You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 1, 2026

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
Christopher H Crane1, Theodore S Hong1, Freddy E Escorcia1
1Christopher H. Crane, MD, Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY; Theodore S. Hong, MD, FASCO, Harvard Medical School, Boston, Massachusetts; Theodore S. Hong, MD, FASCO, Laboratory of Molecular Radiotherapy, National Institutes of Health, Bethesda, MD; Laura A. Dawson, MD, Department of Radiation Oncology, University of Toronto, Toronto, Canada, Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
No abstract available in PubMed .